[Status of surgical studies in oncology. II].
Recent prospective randomised trials dealt with the optimal extent of surgical resection as well as with preoperative therapy modalities in pancreatic, rectal and breast cancer. In pancreatic cancer extended lymphadenectomy did not improve overall survival. Total mesorectal excision remarkably changed surgery for rectal cancer. Rate of local recurrence of rectal cancer could be significantly reduced by preoperative irradiation. In advanced rectal cancers curative resection and sphincter preservation seems possible due to multimodal preoperative therapy. It has been demonstrated that in appropriate cases breast-preserving resection is comparable to mastectomy with respect to overall survival. Up to now it is not quite clear if sentinel node sampling is equivalent to routine lymphadenectomy. Following neoadjuvant chemotherapy breast-preservation rate is significantly higher, but survival is not significantly increased.
Zacherl
J
J
Klinische Abteilung für Allgemeinchirurgie, Allgemeines Krankenhaus der Stadt Wien, Osterreich.
Jakesz
R
R
D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D005544:Forecasting; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D011182:Postoperative Care; D011300:Preoperative Care; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D016032:Randomized Controlled Trials as Topic; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery*; D012106:Research; D013997:Time Factors